Amgen
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.asserted
- Valid from
- 2013-01-01
- Valid until
- still holds
- Published
- 2026-04-07
- Recorded by AsOf
- 2026-11-21
- Checked
- 2026-11-08 · mirrors a checked claim on the organization's record
- Confidence
- 0.95
Sources
Cite this claim
Plain text
AsOf. "Robert A. Bradway chair of: Amgen", as of 2013-01-01. Claim clm_858438A2F017, https://asof.is/claim/clm_858438A2F017, accessed 2026-11-21. Source: https://www.sec.gov/Archives/edgar/data/318154/000119312526145588/d13946ddef14a.htm.
APA
AsOf. (2013). Robert A. Bradway chair of: Amgen (as of 2013-01-01) [Record clm_858438A2F017]. Retrieved November 21, 2026, from https://asof.is/claim/clm_858438A2F017 (source: https://www.sec.gov/Archives/edgar/data/318154/000119312526145588/d13946ddef14a.htm)
BibTeX
@misc{asof_clm_858438A2F017,
author = {AsOf},
title = {Robert A. Bradway chair of: Amgen},
year = {2013},
howpublished = {\url{https://asof.is/claim/clm_858438A2F017}},
note = {Claim clm\_858438A2F017, as of 2013-01-01; source: https://www.sec.gov/Archives/edgar/data/318154/000119312526145588/d13946ddef14a.htm},
urldate = {2026-11-21}
}On the record
/claim/clm_858438A2F017.md/v1/claims/clm_858438A2F017submit a correction